Gan & Lee Pharmaceuticals. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,905.67 million compared to CNY 1,236.89 million a year ago.

Revenue was CNY 1,905.67 million compared to CNY 1,236.89 million a year ago. Net income was CNY 266.48 million compared to net loss of CNY 413.81 million a year ago. Basic earnings per share from continuing operations was CNY 0.47 compared to basic loss per share from continuing operations of CNY 0.74 a year ago.

Diluted earnings per share from continuing operations was CNY 0.47 compared to diluted loss per share from continuing operations of CNY 0.74 a year ago.